VA/DoD CLINICAL PRACTICE GUIDELINE FOR OPIOID THERAPY FOR CHRONIC PAIN

Recommendations

Info

VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain 2010 Recommendation Location 18 2010 Recommendation Text 19 Module Section Number nonadherence 4 M3 1 Inform patients that drug testing is a routine procedure for all patients starting or on opioid therapy, and is an important tool for monitoring the safety of their treatment. 2010 Grade 20 2016 Recommendation (if Category 21 applicable) 22 None Reviewed, New-replaced 4 M3 2 With patient consent, obtain a UDT in all patients prior to initiation of OT. [B] B Reviewed, New-replaced 4 M3 3 With patient consent monitor all patients on OT with periodic random UDTs to confirm adherence to the treatment plan. Increase the frequency of UDTs based on risk level for aberrant drug-related behaviors and following each dose increase. [B] 4 M3 4 Take into consideration a patient’s refusal to take a UDT as part of the ongoing assessment of the patient’s ability to adhere to the treatment plan and the level of risk for adverse outcomes (see Annotation F). 4 M3 5 When interpreting UDT results take into account other clinical information (e.g., past SUD, other risk factors, aberrant drug-related behaviors, and other conditions indicating risk.) 4 M3 6 Understanding of lab methods for drug testing and reporting are necessary to interpret UDT results (i.e., screen versus confirmatory test, substances tested, cut-off levels for tests). Maintain a close working relationship with the clinical laboratory to answer any questions about the UDT or for confirming the results. 4 M4 1 Evaluate and assess the patient for the following problems or other indications for consultation or referral: a. Patient with complex pain conditions b. Patient with significant medical comorbidities that may negatively impact opioid therapy c. Patient with significant concurrent psychiatric illnesses d. Patient who is unable to tolerate increased pain or physical withdrawal symptoms arising from opioid tapering when OT is being discontinued e. Opioid induced hyperalgesia or opioid tolerance suspected (i.e., pain increases or changes while on chronic stable opioid dosing and with an unchanged underlying medical condition causing the pain) f. Patient with conditions requiring management beyond the expertise level of the primary provider B Reviewed, New-replaced None Not reviewed, Deleted None Not reviewed, Deleted None Not reviewed, Deleted None Not reviewed, Deleted Recommendation 7 Recommendation 7 Recommendation 7 February 2017 Page 148 of 192
VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain 2010 Recommendation Location 18 2010 Recommendation Text 19 Module Section Number 4 M5 1 Evaluate pain intensity at each visit. a. Intensity of pain should be measured in the following manner using a Numeric Rating Scale (NSR) (0 to 10) and include the following: • Current pain • Least pain in last week • “Usual” or “Average” pain in the last week b. The patient’s response to current pain medications should be assessed each visit using questions such as: • “What is your intensity of pain after taking your current treatment/medication?” • “How long does your pain relief last after taking your medication?” 4 M5 2 Evaluate pain-related function using objective documentation whenever possible, such as physical therapy progress notes, employment records, exercise diaries, family reports, clinician observations (e.g., walking distance), or validated instruments or NRS rating scales on a monthly basis during the titration phase and every six months after the patient is on stable opioids. Assessment of function may include: • Employment • Enjoyment of life • Emotional distress (depression and anxiety) • Housework, chores, hobbies, and other day to day activities • Sleep • Mobility • Self-care behaviors • Sexual function 2010 Grade 20 2016 Recommendation (if Category 21 applicable) 22 None Not reviewed, Deleted None Not reviewed, Deleted 4 M5 3 Assess overall patient satisfaction with pain therapy at each visit None Not reviewed, Deleted 4 M5 4 Emphasis should be given to capitalizing on improved analgesia by gains in physical and social function; opioid therapy should be considered complementary to other analgesic and rehabilitative approaches. 5 N1 1 Adverse effects can usually be minimized through the use of low starting doses, slow titration rates, prophylactic and symptomatic treatments, and specific patient education provided at initiation of therapy. None Not reviewed, Deleted None Not reviewed, Deleted 5 N1 2 Symptomatic treatment should be augmented with slow dosage titration, dose None Not reviewed, February 2017 Page 149 of 192
Page 1 and 2:
VA/DoD CLINICAL PRACTICE GUIDELINE
Page 3 and 4:
VA/DoD Clinical Practice Guideline
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Appendix D: Drug Tables A. Short-ac
Page 83 and 84:
Short-Acting Opioid Initial Oral Do
Page 85 and 86:
Short-Acting Opioid Initial Oral Do
Page 87 and 88:
Short-Acting Opioid Tramadol (alone
Page 89 and 90:
Long-Acting/ER Opioids 1 Buprenorph
Page 91 and 92:
Long-Acting/ER Opioids 1 Hydrocodon
Page 93 and 94:
Long-Acting/ER Opioids 1 Initial Do
Page 95 and 96:
Long-Acting/ER Opioids 1 Initial Do
Page 97 and 98: Long-Acting/ER Opioids 1 Initial Do
Page 99 and 100: 3 CYP-3A4 inhibiting agents include
Page 101 and 102: VA/DoD Clinical Practice Guideline
Page 147: VA/DoD Clinical Practice Guideline
Page 163 and 164: DRAFT 3 - DO NOT DISTRIBUTE VA/DoD
show all

VA/DoD CLINICAL PRACTICE GUIDELINE FOR OPIOID THERAPY FOR CHRONIC PAIN

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?